Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY -2.61%66 Net Margin % is -4.43% as of Mar. 2026. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Surgery Partners ranks worse than 69.94% on this metric.
Surgery Partners (NAS:SGRY) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Surgery Partners Net Margin % Related Terms
Surgery Partners Net Margin % Historical Data
* Premium members only.
The historical data trend for Surgery Partners's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Surgery Partners's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Net Margin % distribution charts can be found below:
* The bar in red indicates where Surgery Partners's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (SGRY) has a Net Margin % of -4.43% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Surgery Partners and its competitors. According to the industry distribution chart, Surgery Partners ranks #463 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 69.9%.
Is Surgery Partners' Net Margin % too high?
Surgery Partners' current Net Margin % is -4.43%. Based on the distribution chart, Surgery Partners ranks #463 out of 662 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' Net Margin % compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #463 out of 662 companies for Net Margin %. This places Surgery Partners in the lower half of its industry. The industry median Net Margin % is 2.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.97, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current Net Margin % is -4.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current Net Margin % is -4.43%. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Surgery Partners (SGRY), the current Net Margin % is -4.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
Net Margin %: -4.43%
GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score
Get the complete analysis for SGRY
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
